Xynos Konstantinos (CIK 1956241) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-12). Recent activity: Sell REPL (11,447 shares), Sell REPL (14,023 shares), Buy REPL (50,000 shares), Buy REPL (60,000 shares), Sell REPL (7,248 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Sell | 11,447 | $148,468 |
| 2026-05-20 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Sell | 14,023 | $71,237 |
| 2026-04-07 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Buy | 50,000 | $0 |
| 2025-12-19 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Buy | 60,000 | $0 |
| 2025-11-19 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Sell | 7,248 | $65,957 |
| 2025-05-22 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Sell | 7,952 | $64,093 |
| 2025-04-03 | Replimune Group, Inc. (REPL) | Chief Medical Officer | Buy | 45,000 | $0 |
Source: SEC Form 4 filings · as of 2026-08-12